{"name":"Cellectis S.A.","slug":"cellectis-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"UCART123v1.2","genericName":"UCART123v1.2","slug":"ucart123v1-2","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"UCART123v1.2","genericName":"UCART123v1.2","slug":"ucart123v1-2","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5DdmxHYnNyWjFBUUNJaGtXaWhNcWxDTGc4WWVER1NZTUFHOHZCeDlLMVZxSXFZNE1TT2V6RW81RTkzM1Y0VDc2Z3UyZGp4R2hCUzZfNmVZY0lpVW1UMDc2OU13dVRtVXRzdDFB?oc=5","date":"2026-03-29","type":"pipeline","source":"Reuters","summary":"(ALCLS.PA) | Stock Price & Latest News - Reuters","headline":"(ALCLS.PA) | Stock Price & Latest News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQUkJBSFcwbHFrdlJBUnduVE9WTEtJM3NvWjF3SkIwdENXd1A4b1dGcE9pY3N3M2piY1ctQUpyVXlOYk80dlQ1dlU4MVFqMDZ0V1NiUjdPTnZ3MndacHNoaWV5azdueGJ1Tzh3dk9JSWo2Z0hJWFlkRWpvellxbmo0Y2RPUXdpMjlCNi1OYUE0MEZFbW8?oc=5","date":"2026-02-05","type":"regulatory","source":"BioWorld News","summary":"Cancer index surges 72% as Terns, Olema lead gains - BioWorld News","headline":"Cancer index surges 72% as Terns, Olema lead gains","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOczFQaHVsWk96ODh5ZGhsZXM1WmhwZ2RTWTBUZGxpSUVIZS1MNkFqWXY0azNsQWZ0aG0yUS00bTVvTUVMX21QOFRKU3NXMTd3Q1Z0OEFxRHg0Sy11Q2ZMV0VJN0R1dFJMUmtDYzJQZDYzMXY4ZkEtN3hYUEt1a01iaXZPZThqWmowX2ExcHJtYWRpd09UME5RZXQ2d0d3eDBs?oc=5","date":"2025-12-11","type":"deal","source":"seekingalpha.com","summary":"Cellectis’ Allogeneic CAR-T Potential Still Justifies A “Buy” (NASDAQ:CLLS) - seekingalpha.com","headline":"Cellectis’ Allogeneic CAR-T Potential Still Justifies A “Buy” (NASDAQ:CLLS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNT2EwVDA1QTljMDViWTJzbXk0T181bThWYlgtN2preGFOVWk0Vk1sQk9qQzlna2xrcEVjaUNhX3U2LUZ3cnRsRVBDZjdoWmo0TTFWb2dGX1JtUmQ3aUUyOGxsa1VBcU5IaXhwUU0wWGJsZnllaU52TlNrNHhoMXJNSDlQLXpGNUxJWFNhZzAxcXVFalBVWk84WlJLRXNuYS1CbGhVc0tKMzd4cUY0b2VmdngyR0xMeEJacUVCNldNYlh0azI5TDJWX2FOczNCeUJYMkY0WE5wemJDNDNxbmFCb1FKVkIwMFVodExtdV9lZWg1Qm5t?oc=5","date":"2025-10-20","type":"regulatory","source":"Benzinga","summary":"Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga","headline":"Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxORDdRaFFSUEU2c2xSYlc1SFV2MWw4VDlOalJsZjliM1pTY0Q5YnREYXdBOU53bGkyWE9lNWJMUFZFOVhJT2hmR1p5cDRWTUluVFRma0VNX0pUa0hNblFZcS1zZENGS21KRWo1c1lZcXFNQmI2blZFZnlCZXgwLVlJeEx3RHR1eGxpaEQ3cGNlVzE5NVJsbWlTVFlxa1dTS3V0QllJa0tVWXo3a09HdjI1ZVFmQUZnZnZVTmZUYXoxN2ZyQ3E1ZklJZQ?oc=5","date":"2025-09-29","type":"patent","source":"BioPharma APAC","summary":"Factor Bioscience Files Patent Infringement Lawsuit Against Cellectis and AstraZeneca - BioPharma APAC","headline":"Factor Bioscience Files Patent Infringement Lawsuit Against Cellectis and AstraZeneca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQbXQyT3hRUGZVd0FBNjdhOGVMeVFhTm90d3lrMnVZNExaN2NQZWdLWTFCeTJRb3hwamd1UHdEaVpQeW1zTVNNX3o5ckdTZHhtdzBMWWtsRU96R0FDZXhtbDRqT1Q0VzB6d1pudVRabWNWdWN0dmFmS2I1YnZ1V3NkQ2luRW5XQ08zY2JJWmNQc1B4Umd5b1doS21HTFpEdWw3ZTVlRXJBOWdKRGI0MDJpQk9XSnN6dm5WOFIzYnN3NG9JWDBlblE?oc=5","date":"2025-09-26","type":"patent","source":"Reuters","summary":"AstraZeneca, Cellectis targeted in patent lawsuit over gene-editing technology - Reuters","headline":"AstraZeneca, Cellectis targeted in patent lawsuit over gene-editing technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNMXUzQm9VWnA0UXBmN1dDcGpFajBWRV9xNk9lWGdpMzBmcTc1UTVmRjV0NU9OdjJDTVpPcXdQSEhnTGFaY044VW5ZVFA3SWN4OGZBeUFoaWgyMHJOMXFYallNNWRzT2R3M0pINDVPZmJiVjJMMmR3S2RwXzBONU1CS0dUMUk3eTg5MXBaMzR0akpJMmhkcVBYWDJlWVA0SldzQnJEd2hn?oc=5","date":"2025-02-18","type":"pipeline","source":"BioSpace","summary":"U.S. Genome Editing Market Size to Hit USD 16.49 Billion by 2033 - BioSpace","headline":"U.S. Genome Editing Market Size to Hit USD 16.49 Billion by 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOQU5mV1JxWWxwSUlJYUdadXVKd3F5RFpoUTRqazI2Qkh0UFZ5MEoxSVliQVNXbWRQbGtRay1CVEdTYVBWNUxISUN6VEZfZzNTS1J6LUxpQlE2WC1aZGFfWmdVRjlvcHVXVEpZQ2VBRk1tYVFEZmNLbmR3UDl4ZmxwOEJjZ2xNOFJTWXdSNlJpVEFtT0QwUE1Bb2JZOHdOZWc3VjNNVC1TaXlIR01sRkZ3NWdtSlh1TmM?oc=5","date":"2023-11-01","type":"deal","source":"AstraZeneca","summary":"AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions - AstraZeneca","headline":"AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNYzhOaC10WVIwOWotbkxLVmNZNC1US3pvQkJ4YnhTSGxXQml5bnpVeGhFcDMtQkZIc0lubGRDR2V5T0VwbjVMWkRtbkNCbTNCbFM3U1dDUTZXLWJWZ2RwUXB2dGhZRFpDQ096Tm1HV1hQQ2o3cE1Mb0FxX3NCVXFVTlJQNDhZNFJMczhZYTlvLWV5eTlVQjlmT3c5RXhfaXFPMi1oNm5nd0pXeGtyOHpZ?oc=5","date":"2022-03-25","type":"pipeline","source":"Contract Pharma","summary":"Catalent Appoints Dr. Frederic Cedrone as VP, Corporate Innovation - Contract Pharma","headline":"Catalent Appoints Dr. Frederic Cedrone as VP, Corporate Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNNUNzdTFramNSSldtemxZSXhSa2xwczFDZU9yVjNWU0hmV3Jkem1QR3NDdDdwRDRnTm1OSDJONmhkS1ptSG50UDN5VE9vWEdPTGszSGkxaS1zODBEcTFoUnRBZUFkNUZwYUFKV3p6R1o5RjcyWDFJLUkwRXJ1cGE3VW5LRlB3cXB4ZWpULXplcURVTk1URDQyUE5zVjZFcW5QNVJnWm9JdVo1dw?oc=5","date":"2018-04-03","type":"deal","source":"BioPharma Dive","summary":"Pfizer inks deal handing CAR-T assets to newly launched biotech - BioPharma Dive","headline":"Pfizer inks deal handing CAR-T assets to newly launched biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQaWdJR21QSlo5SUI3NDRJM0Z4dmlPbF8tbmtBdzRzcGRURTRxVFZ5VlQ3OGlwVHM1VzBIUnZGRXNSQ3ViXzg2QmpYV2h5YkU2VXdLZ3daYlRPX1pfSk1ZeVd5R2Qzblkyak1zVGVFd1poSEJtNWY2ZFlRdFdqQVhGU1VLdUpkTDBpcTlPTlJfd3h5RlNacGl6cGVIcmFhbW1IZVlpTjVRZ0ViT09td25oVUFoMUxGN2s5RXpQc2RzQkxVYzhIeGRF?oc=5","date":"2017-09-05","type":"regulatory","source":"Fierce Biotech","summary":"FDA hits Cellectis’ off-the-shelf CAR-T program with clinical hold after first patient treated in phase 1 trial dies - Fierce Biotech","headline":"FDA hits Cellectis’ off-the-shelf CAR-T program with clinical hold after first patient treated in phase 1 trial dies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE44ZWE1M3RvZjlVVGFIUjZRbC1BMjBLU3gzcVpyV3lkc0Z1Ynctc0ozVjREdWxZQVh5aE9HZ0R2c3NmTEk3QlNQc3NiYXJYX2JmZGNPVGpkakpoUQ?oc=5","date":"2016-08-12","type":"pipeline","source":"MarketBeat","summary":"Cellectis (CLLS) Stock Price, News & Analysis $CLLS - MarketBeat","headline":"Cellectis (CLLS) Stock Price, News & Analysis $CLLS","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}